Stock Analysts’ updated eps estimates for Friday, February 7th:
Affirm (NASDAQ:AFRM) had its hold rating reissued by analysts at Needham & Company LLC.
Amazon.com (NASDAQ:AMZN) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $250.00 price target on the stock.
Amazon.com (NASDAQ:AMZN) had its overweight rating reiterated by analysts at Piper Sandler. They currently have a $265.00 target price on the stock, up from their previous target price of $225.00.
Amazon.com (NASDAQ:AMZN) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $280.00 target price on the stock.
Amazon.com (NASDAQ:AMZN) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $285.00 target price on the stock.
Amazon.com (NASDAQ:AMZN) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $270.00 price target on the stock.
Air Products and Chemicals (NYSE:APD) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $320.00 target price on the stock, down from their previous target price of $345.00.
Arvinas (NASDAQ:ARVN) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald.
BILL (NYSE:BILL) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a $105.00 target price on the stock.
BILL (NYSE:BILL) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $85.00 price target on the stock.
BILL (NYSE:BILL) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $100.00 price target on the stock.
Boyd Gaming (NYSE:BYD) had its market perform rating reissued by analysts at JMP Securities.
Clearfield (NASDAQ:CLFD) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $50.00 price target on the stock.
CleanSpark (NASDAQ:CLSK) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $27.00 price target on the stock.
CMS Energy (NYSE:CMS) had its neutral rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $69.00 price target on the stock.
Corcept Therapeutics (NASDAQ:CORT) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $80.00 target price on the stock.
Sprinklr (NYSE:CXM) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $17.00 price target on the stock.
Sprinklr (NYSE:CXM) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $10.50 target price on the stock.
Cytokinetics (NASDAQ:CYTK) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $78.00 target price on the stock.
DraftKings (NASDAQ:DKNG) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $60.00 price target on the stock.
Doximity (NASDAQ:DOCS) had its outperform rating reissued by analysts at Raymond James. The firm currently has a $83.00 target price on the stock, up from their previous target price of $65.00.
Equifax (NYSE:EFX) had its outperform rating reiterated by analysts at William Blair.
Encompass Health (NYSE:EHC) had its outperform rating reiterated by analysts at William Blair.
e.l.f. Beauty (NYSE:ELF) had its neutral rating reissued by analysts at UBS Group AG. They currently have a $74.00 price target on the stock, down from their previous price target of $158.00.
e.l.f. Beauty (NYSE:ELF) had its equal weight rating reaffirmed by analysts at Morgan Stanley. They currently have a $70.00 price target on the stock, down from their previous price target of $153.00.
e.l.f. Beauty (NYSE:ELF) had its buy rating reissued by analysts at B. Riley. The firm currently has a $90.00 target price on the stock, down from their previous target price of $150.00.
Enlivex Therapeutics (NASDAQ:ENLV) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $13.00 target price on the stock.
Expedia Group (NASDAQ:EXPE) had its market perform rating reaffirmed by analysts at JMP Securities.
Expedia Group (NASDAQ:EXPE) had its buy rating reissued by analysts at B. Riley. The firm currently has a $235.00 target price on the stock, up from their previous target price of $220.00.
Expedia Group (NASDAQ:EXPE) had its neutral rating reissued by analysts at Cantor Fitzgerald. They currently have a $210.00 target price on the stock, up from their previous target price of $180.00.
Extreme Networks (NASDAQ:EXTR) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $22.00 target price on the stock.
Fortinet (NASDAQ:FTNT) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Fortinet (NASDAQ:FTNT) had its neutral rating reissued by analysts at Guggenheim.
Fortinet (NASDAQ:FTNT) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $135.00 price target on the stock, up from their previous price target of $120.00.
Genfit (NASDAQ:GNFT) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $13.00 price target on the stock.
Haemonetics (NYSE:HAE) had its strong-buy rating reaffirmed by analysts at Raymond James. They currently have a $115.00 target price on the stock, down from their previous target price of $120.00.
Huntington Bancshares (NASDAQ:HBAN) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $18.50 target price on the stock.
Horace Mann Educators (NYSE:HMN) had its market perform rating reaffirmed by analysts at JMP Securities.
Leslie’s (NASDAQ:LESL) had its neutral rating reiterated by analysts at Guggenheim.
Lumentum (NASDAQ:LITE) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $110.00 price target on the stock.
Lumentum (NASDAQ:LITE) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $110.00 target price on the stock.
Microchip Technology (NASDAQ:MCHP) had its buy rating reissued by analysts at B. Riley. The firm currently has a $75.00 target price on the stock, down from their previous target price of $85.00.
Microchip Technology (NASDAQ:MCHP) had its strong-buy rating reissued by analysts at Raymond James. Raymond James currently has a $60.00 target price on the stock, down from their previous target price of $95.00.
Microchip Technology (NASDAQ:MCHP) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $65.00 target price on the stock, down from their previous target price of $85.00.
Mesoblast (NASDAQ:MESO) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $24.00 price target on the stock, up from their previous price target of $15.00.
Neurocrine Biosciences (NASDAQ:NBIX) had its hold rating reaffirmed by analysts at Needham & Company LLC.
Neurocrine Biosciences (NASDAQ:NBIX) had its outperform rating reiterated by analysts at William Blair.
NIKE (NYSE:NKE) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $84.00 price target on the stock.
Omega Healthcare Investors (NYSE:OHI) had its market perform rating reissued by analysts at JMP Securities.
Onsemi (NASDAQ:ON) had its neutral rating reissued by analysts at Rosenblatt Securities. They currently have a $75.00 target price on the stock.
Onto Innovation (NYSE:ONTO) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $230.00 price target on the stock.
Onto Innovation (NYSE:ONTO) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $250.00 price target on the stock.
Onto Innovation (NYSE:ONTO) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $230.00 target price on the stock.
Oruka Therapeutics (NASDAQ:ORKA) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $45.00 target price on the stock.
Blue Owl Capital (NYSE:OWL) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $32.00 price target on the stock, up from their previous price target of $30.00.
Procore Technologies (NYSE:PCOR) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $90.00 price target on the stock.
Paylocity (NASDAQ:PCTY) had its outperform rating reissued by analysts at Raymond James. Raymond James currently has a $265.00 target price on the stock, up from their previous target price of $215.00.
PepsiCo (NASDAQ:PEP) had its market perform rating reaffirmed by analysts at CICC Research.
Pinterest (NYSE:PINS) had its neutral rating reissued by analysts at Piper Sandler. The firm currently has a $41.00 price target on the stock, up from their previous price target of $36.00.
Pinterest (NYSE:PINS) had its buy rating reissued by analysts at Stifel Nicolaus. They currently have a $50.00 price target on the stock, up from their previous price target of $45.00.
Power Integrations (NASDAQ:POWI) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $78.00 target price on the stock.
Perdoceo Education (NASDAQ:PRDO) had its outperform rating reiterated by analysts at Barrington Research. Barrington Research currently has a $32.00 target price on the stock.
PROS (NYSE:PRO) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $30.00 price target on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $58.00 target price on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $50.00 target price on the stock.
Palatin Technologies (NYSEAMERICAN:PTN) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $17.00 price target on the stock.
Peloton Interactive (NASDAQ:PTON) had its market perform rating reiterated by analysts at JMP Securities.
Paycor HCM (NASDAQ:PYCR) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $22.50 price target on the stock, down from their previous price target of $28.00.
QUALCOMM (NASDAQ:QCOM) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $240.00 target price on the stock.
QuinStreet (NASDAQ:QNST) had its buy rating reissued by analysts at B. Riley. B. Riley currently has a $34.00 target price on the stock, up from their previous target price of $32.00.
QuinStreet (NASDAQ:QNST) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $29.00 price target on the stock.
Rani Therapeutics (NASDAQ:RANI) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $9.00 price target on the stock.
Selective Insurance Group (NASDAQ:SIGI) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $93.00 target price on the stock, down from their previous target price of $116.00.
Silicon Motion Technology (NASDAQ:SIMO) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $70.00 target price on the stock.
Skechers U.S.A. (NYSE:SKX) had its hold rating reiterated by analysts at Needham & Company LLC.
Sonos (NASDAQ:SONO) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $18.00 price target on the stock.
Tapestry (NYSE:TPR) had its outperform rating reiterated by analysts at Raymond James. They currently have a $88.00 price target on the stock, up from their previous price target of $79.00.
Take-Two Interactive Software (NASDAQ:TTWO) had its outperform rating reiterated by analysts at Raymond James. Raymond James currently has a $220.00 price target on the stock, up from their previous price target of $190.00.
Take-Two Interactive Software (NASDAQ:TTWO) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $225.00 price target on the stock, up from their previous price target of $210.00.
Under Armour (NYSE:UAA) had its neutral rating reiterated by analysts at Guggenheim.
Under Armour (NYSE:UAA) had its hold rating reiterated by analysts at Needham & Company LLC.
Veeco Instruments (NASDAQ:VECO) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $35.00 price target on the stock, down from their previous price target of $40.00.
Viking Therapeutics (NASDAQ:VKTX) had its buy rating reiterated by analysts at B. Riley. The firm currently has a $96.00 price target on the stock, down from their previous price target of $109.00.
Varex Imaging (NASDAQ:VREX) had its buy rating reiterated by analysts at B. Riley. B. Riley currently has a $22.00 price target on the stock, up from their previous price target of $21.00.
Viasat (NASDAQ:VSAT) had its market perform rating reiterated by analysts at William Blair.
Warner Music Group (NASDAQ:WMG) had its buy rating reissued by analysts at Guggenheim. They currently have a $40.00 target price on the stock.
Advanced Drainage Systems (NYSE:WMS) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $135.00 price target on the stock.
X4 Pharmaceuticals (NASDAQ:XFOR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $1.50 target price on the stock.
XPeng (NYSE:XPEV) had its neutral rating reaffirmed by analysts at Macquarie. The firm currently has a $18.00 target price on the stock.
Zimmer Biomet (NYSE:ZBH) had its hold rating reiterated by analysts at Needham & Company LLC.
Zimmer Biomet (NYSE:ZBH) had its market outperform rating reiterated by analysts at JMP Securities. The firm currently has a $140.00 price target on the stock.
Receive News & Ratings for Affirm Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affirm Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
